Oxidized-LDL Enhances Coronary Vasoconstriction by Increasing the Activity of Protein Kinase C Isoforms α and ε

作者: Jena B. Giardina , Dennis J. Tanner , Raouf A. Khalil

DOI: 10.1161/01.HYP.37.2.561

关键词:

摘要: Oxidized low-density lipoprotein (ox-LDL) plays a critical role in the development of atherosclerotic coronary vasospasm; however, cellular mechanisms involved are not fully understood. We tested hypothesis that ox-LDL enhances vasoconstriction by increasing activity specific protein kinase C (PKC) isoforms smooth muscle. Active stress was measured de-endothelialized porcine artery strips; cell contraction and [Ca 2+ ] i were monitored single muscle cells loaded with fura-2; cytosolic particulate fractions examined for PKC reactivity isoform-specific anti-PKC antibodies Western blots. Ox-LDL (100 μg/mL) caused slow but significant increases active to 1.3±0.4×10 3 N/m 2 (10%) completely inhibited GF109203X (10 −6 mol/L), an inhibitor Ca -dependent -independent isoforms, no change . 5-Hydroxytryptamine (5-HT; 10 −7 mol/L) KCl (24 mmol/L) channel blocker verapamil mol/L). enhanced 5-HT additional Direct activation phorbol 12-myristate13-acetate (PMA; similar magnitude time course ox-LDL–induced 5-HT– KCl-induced The enhancement Go6976 isoforms. Both PMA increase fraction, decrease particulate/cytosolic ratio. blots revealed PKC-α PKC-δ, -e, -ζ In unstimulated tissues, PKC-α- -e mainly cytosolic, PKC-δ PKC-ζ equally distributed fractions. alone or translocation PKC-e from whereas distribution pattern PKC-α, -δ, remained unchanged. did activity. tissues pretreated PMA, Native LDL significantly affect contraction, , These results suggest causes via -increasing agonists activating PKC-α. Activation may represent possible mechanism which could enhance vasospasm.

参考文章(37)
Barry M. Brenner, John H. Laragh, Hypertension : pathophysiology, diagnosis, and management Raven Press. ,(1995)
R. A. Khalil, C. Lajoie, M. S. Resnick, K. G. Morgan, Ca(2+)-independent isoforms of protein kinase C differentially translocate in smooth muscle American Journal of Physiology-cell Physiology. ,vol. 263, ,(1992) , 10.1152/AJPCELL.1992.263.3.C714
H. E. Andrews, K. R. Bruckdorfer, R. C. Dunn, M. Jacobs, Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature. ,vol. 327, pp. 237- 239 ,(1987) , 10.1038/327237A0
Kiyotaka Kugiyama, Scott A. Kerns, Joel D. Morrisett, Robert Roberts, Philip D. Henry, Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. ,vol. 344, pp. 160- 162 ,(1990) , 10.1038/344160A0
Kunio Yagi, A simple fluorometric assay for lipoperoxide in blood plasma Biochemical Medicine. ,vol. 15, pp. 212- 216 ,(1976) , 10.1016/0006-2944(76)90049-1
U. P. Steinbrecher, S. Parthasarathy, D. S. Leake, J. L. Witztum, D. Steinberg, Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids Proceedings of the National Academy of Sciences of the United States of America. ,vol. 81, pp. 3883- 3887 ,(1984) , 10.1073/PNAS.81.12.3883
J W Heinecke, H Rosen, A Chait, Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. Journal of Clinical Investigation. ,vol. 74, pp. 1890- 1894 ,(1984) , 10.1172/JCI111609
T Henriksen, E M Mahoney, D Steinberg, Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 3, pp. 149- 159 ,(1983) , 10.1161/01.ATV.3.2.149